Back to companies

Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization

Showing 10 out of 24 companies.

Johnson & Johnson, Eli Lilly and Co, AbbVie Inc, Novo Nordisk AS, and Merck & Co Inc are the top 5 pharmaceutical companies in the world in 2023 by market cap (as of Mar 31, 2023). Comprehensively, the top 10 pharma companies in the world in 2022 had a market cap of $ 2,591,949 million (as of Mar 31, 2023), with Johnson & Johnson Ltd having the highest ($402,750 million), followed by Eli Lilly and Co ($327,055 million), and AbbVie Inc ($281,151 million), while Bristol-Myers Squibb Co has the lowest ($145,780 million). The US-based Johnson & Johnson is the leading pharma company in the world by market capitalization. The company reported revenues of $94,943 million for the fiscal year ended January 2022 (FY2022), an increase of 1.2% over FY2021. The Company research, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company conducts its business through more than 260 subsidiaries and 85 manufacturing facilities in over 60 countries globally and employs 152,700 people. Novartis AG (Novartis) is another leading pharma company in the world by market capitalization. The company reported revenues of $51,742 million for the fiscal year ended December 2022 (FY2022), a decrease of 2.1% over FY2021. The company focuses on the discovery, development, manufacturing, and marketing of prescription and generic pharmaceutical products and eye care products. Novartis conducts research in various disease areas through The Novartis Institutes for BioMedical Research (NIBR). The company operates through a network of subsidiaries and offices across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. It employs 101,703 people.

Eli Lilly and Co

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

869,016

Johnson & Johnson

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

588,761

AbbVie Inc

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

384,688

Novartis AG

Headquarters

Switzerland

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

307,949

AstraZeneca Plc

Headquarters

United Kingdom

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

301,175

Merck & Co Inc

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

297,404

Amgen Inc

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

189,671

Gilead Sciences Inc

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

172,989

Pfizer Inc

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

159,729

Bristol-Myers Squibb Co

Headquarters

United States of America

Sector

Pharmaceuticals and Healthcare

Parent/Subsidiary/Independent

Parent

Market Cap ($M, Mar 31, 2026)

123,831

Showing 10 out of the top 24 companies.
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer